Skip to Main Content

Paper Details

A different method of evaluation of the ERSPC trial confirms that prostate-specific antigen testing has a significant impact on prostate cancer mortality.
Eur Urol
11
2014
Author NameAffiliation
Maciej KwiatkowskiAcademic Hospital Braunschweig
Monique J Roobol
  • 1 - 2

Datasets

Release 1.2